According to a new report, published by KBV research, The Global Ovulation Testing Kits Market size is expected to reach $3.7 billion by 2030, rising at a market growth of 6.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 5,06,912.7 thousand units, experiencing a growth of 4.8% (2019-2022).
The Urine Ovulation Test segment is leading the Global Ovulation Testing Kits Market, by Product in 2022 thereby achieving a market value of $1.9 billion by 2030. Urine ovulation tests are designed to detect the luteinizing hormone (LH) surge that occurs just before ovulation. This surge is a reliable indicator of impending ovulation, making these tests highly accurate in predicting the multiple fertile periods of a woman's menstrual cycle. These tests are simple to use and provide results in just a few minutes. They are convenient and can be used in the comfort of one's home. Most kits come with clear instructions, making them user-friendly. These tests are relatively inexpensive compared to other fertility tracking methods or medical interventions. They offer a cost-effective way for women to monitor their ovulation and improve their chances of conceiving.
The Pharmacies & Drugstores is showcasing a CAGR of 5.8% during the forecast period. Pharmacies and drugstores usually carry various brands and types of ovulation testing kits. This lets customers choose the brand and format that best suits their needs and preferences. Many pharmacies and drugstores have extended hours of operation. They are open on weekends, offering convenience to individuals needing to purchase these kits at different times of the day or week. Some pharmacies and drugstore chains offer private-label or store-brand ovulation testing kits, which can be a more affordable alternative to nationally recognized brands.
The North America region dominated the Global Ovulation Testing Kits Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.3 billion by 2030. The Europe market is anticipated to grow at a CAGR of 6.2% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 7.1% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/ovulation-testing-kits-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AccuQuik Testkits (AdvaCare Pharma), Fairhaven Health, LLC, Equinox Biotech Co., Ltd., Wondfo Biotech Co., Ltd, Pregmate, SPD Swiss Precision Diagnostics GmbH, Proov, Roman Health Ventures Inc. (Ro), Premom (Easy@Home Fertility), and Piramal Enterprises Limited.
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Distribution Channel (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings 
